Empowering Neurovascular Innovation in Sofia, Bulgaria! 🧠✨ A huge thank you to Prof. Stanimir Sirakov and the outstanding Neuro team at St. Ivan Rilski University Hospital for hosting an exceptional Neurovascular Workshop on July 10th, 2025! 📅 With the great coordination of our local partners at Think Tank 🤝, the event featured: Live case demonstrations and Hands-on sessions focused on the Hemorrhagic WallabyPhenox portfolio. It was a fantastic opportunity to exchange knowledge, refine techniques, and strengthen our shared commitment to advancing neurointerventional care. 💡🧠 We’re proud to support such impactful educational initiatives and look forward to many more collaborations. 🚀 #WallabyPhenox #NeuroIntervention #Sofia2025
phenox
Herstellung medizinischer Geräte
Bochum, NRW 8.460 Follower:innen
Leading Innovator in Interventional Neuroradiology
Info
Seit seiner Gründung im Jahr 2005 widmet sich phenox der Entwicklung innovativer, wegweisender und klinisch bewährter Technologien und Lösungen für die Behandlung neurovaskulärer Erkrankungen. Die Produkte von phenox werden weltweit von interventionellen Neuroradiologen zur Behandlung von ischämischen und hämorrhagischen Schlaganfällen eingesetzt. Unser Unternehmen bietet ein wachsendes Portfolio innovativer Behandlungsmöglichkeiten, einschließlich der bereits primär verwendeten interventionellen Technologien. Unser Produktportfolio umfasst das mechanische Thrombektomie-System pRESET, die p64, p48 MW und p64 MW Flow Diverter zur Behandlung komplexer intrakranieller Aneurysmen und Dissektionen sowie das pCONUS Implantat für die Behandlung komplexer, breitbasiger Bifurkationsaneurysmen. Die speziell entwickelte HPC Technologie (Hydrophilic Polymer Coating) für die Produkte zur Aneurysma-Behandlung führt zu einer Verminderung der Thrombogenität der Implantatoberfläche und somit zu einer gesteigerten Patientensicherheit. Seit dem Jahr 2020 vertreibt phenox zudem exklusiv das in Kalifornien (USA) entwickelte Avenir Coiling System der Firma Wallaby Medical. Unser Head Office ist im Technologiepark in Bochum angesiedelt. Darüber hinaus befinden sich weitere internationale Niederlassungen in Galway (Irland), Irvine (CA, USA), Sao Paulo (Brasilien) sowie Mailand (Italien). Weitere Informationen zu phenox und den Produkten finden Sie auf unserer Homepage: https://www.phenox.info/ Impressum: https://phenox.net/international/imprint/
- Website
-
https://www.phenox.net/
Externer Link zu phenox
- Branche
- Herstellung medizinischer Geräte
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Bochum, NRW
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2005
- Spezialgebiete
- Neuroradiology, Medical Technology, Medical Devices, Interventional Neuroradiology, Aneurysm Treatment Devices, Ischemic Stroke Treatment Devices, Flow Modulation Devices, Thrombectomy Devices, Balloon Catheters, Microguidewires, Hydrophilic Polymer Coatings, Bifurcation Aneurysm Implants und MedTech
Orte
Beschäftigte von phenox
Updates
-
Showcasing WallabyPhenox Latest Innovation in NeuroIntervention at LINNC 2025 🧠 Together with a passionate group of neurointerventionalists, we explored advanced techniques and real-world applications of our cutting-edge devices—designed to elevate outcomes in hemorrhagic & ischemic stroke treatment. 💡 The sessions fostered dynamic discussions, live hands-on, and invaluable peer-to-peer exchange. A big thank you to all the participants who brought their expertise and curiosity to the table! Let’s relive the excitement with us by watching the video below! ⬇️ Stay tuned for more opportunities to connect, learn, and innovate together. All credits for this video go to SLICE and Master & Fellow teams, thank you for capturing these moments. #LINNC2025 #Wallabyphenox #Neurointervention #HandsOnChallenge #SLICE
-
Thanks to the COATING study, the HPC Coated Flow Diverters are SAFE TO USE WITH SAPT 👏 For more details, listen to Pr Pierot and Pr Clarençon during their 2025 LINNC interview ⬇️ #wallabyphenox #HPCcoating #p64MWHPC #FlowDiverters
COATING trial: a game-changer in #aneurysm treatment? Frédéric Clarençon & Laurent Pierot share 1-month results from the first randomized controlled trial evaluating a coated flow diverter. 🔍 Discover key safety and efficacy insights 🎥 Watch now: https://ow.ly/USsZ50WaVjK
-
-
New Frontiers in Intracranial Aneurysm Treatment 📑 Thanks to the 𝘾𝙊𝘼𝙏𝙄𝙉𝙂 𝙍𝙖𝙣𝙙𝙤𝙢𝙞𝙯𝙚𝙙 𝘾𝙤𝙣𝙩𝙧𝙤𝙡𝙡𝙚𝙙 𝙏𝙧𝙞𝙖𝙡, the #HPC coated Flow Diverters are now proven safe for use with SAPT! 👏 Learn more here: https://lnkd.in/g-kfWFen #COATING #NewFrontiers
-
phenox hat dies direkt geteilt
Clinically driven 🧠 Watch p48 MW HPC Live in action with Professor Frédéric Clarençon! p48 MW HPC is the only Flow Diverter engineered to treat distal aneurysms with a proven coating, thanks to the COATING Randomized Control Trial Sponsored by WallabyPhenox WallabyPhenox WallabyPhenox Frédéric Clarençon
-
✨It has been an exceptional week at LINNC Paris 2025 for WallabyPhenox! 1️⃣ On Day 1, Professor Laurent Pierot presented the preliminary data from The 𝐂𝐎𝐀𝐓𝐈𝐍𝐆 𝐓𝐫𝐢𝐚𝐥- the first RCT -the highest standard in clinical evidence - evaluating the safety and performance of our p64 MW HPC flow modulation devices under single antiplatelet therapy, compared to our p64 MW device under dual antiplatelet therapy, 𝐩𝐫𝐨𝐯𝐢𝐧𝐠 𝐧𝐨𝐧-𝐢𝐧𝐟𝐞𝐫𝐢𝐨𝐫𝐢𝐭𝐲. 🌟 During our symposium Professor René Chapot, shared in depth his case series with 𝐩𝐄𝐆𝐀𝐒𝐔𝐒 𝐇𝐏𝐂 across the diverse indications where he had the opportunity to benefit from the device, which included cases on rescue stenting, treatment of ICAD, aneurysm bridging and dissections. 👏🏻 2️⃣ On Day 2, the day kicked off with a live performed by Dr. Markus Holtmannspötter using the 𝐩𝟔𝟒 𝐌𝐖 𝐇𝐏𝐂 to treat a fusiform M2 aneurysm. He highlighted the precision and power of the 𝐦𝐨𝐯𝐚𝐛𝐥𝐞 𝐰𝐢𝐫𝐞, a feature that proved essential in navigating this complex case! 🧠 We were excited to collaborate with SLICE and Sim&Cure this year 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐭𝐢𝐦𝐞, where we were collaboratively able to benefit from a strong environment of shared learning! 🤝🏻 Additionally, we were thrilled to see our #TechSuite filled with enthusiastic participants that had the opportunity to see our commercialized portfolio, in addition to our innovation of the near future! 🌐 🙌🏻 Thank you to everyone who participated and contributed to the success of this event. But that’s it for now, stay tuned for more exciting news from #WallabyPhenox 👋🏻 #Neurointervention #LINNCParis #HPC #SLICE #SIMANDCURE
-
-
-
-
-
+9
-
-
🧠 Clinically Driven Master the Art of Rescue Stenting: pEGASUS in the Spotlight at #LINNC 2025 Step into the future of ICAD treatment with a high-impact symposium led by renowned neurointerventionist Prof. René Chapot. 🌐 Discover how the pEGASUS device is transforming rescue stenting and elevating outcomes in complex intracranial atherosclerotic disease (ICAD) cases. 👏🏻 🗓 Monday, June 2, 2025 🕜 13:30 – 13:45 📍 Main Conference Room, LINNC Paris Don't miss out on this opportunity and see you there! 👋🏻 #WallabyPhenox #LINNC2025 #pEGASUS
-
-
🔔 Just a reminder: don't miss the opportunity to join the 𝗦𝗟𝗜𝗖𝗘 𝗵𝗮𝗻𝗱𝘀-𝗼𝗻 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 𝗮𝘁 𝗟𝗜𝗡𝗡𝗖 𝗣𝗮𝗿𝗶𝘀 𝟮𝟬𝟮𝟱 and discover a new way of learning the #WallabyPhenox products! 🙌🏻 Link to registration below! ⬇️ #WallabyPhenox #SLICE #LINNC2025
📢EMERGENCY CALL ! François, Michelle and Simone need your help at LINNC online Paris !📢 Three rare and challenging cases where being ready can mean saving a life: « Preventing fishmouth with FD » - « Giant pediatric aneurysm » - Bilateral Carotid Occlusion ». In the presence of Vincent Costalat, SLICE Course Director, and under the guidance of the LINNC Faculty. Whether you're looking to test your skills or sharpen them, our experts will guide you through in depth discussions and hands-on learning. 🧠 You think you can handle these two cases ? Prove it by joining our exclusive 2 hours session, supported by WallabyPhenox! Register now to secure your spot at SLICE hands-on challenge: 👉 https://lnkd.in/edAaRXHM #LINNCParis #workshops #challenge #hemorragic
-
Join the 𝗦𝗟𝗜𝗖𝗘 𝗵𝗮𝗻𝗱𝘀-𝗼𝗻 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 𝗮𝘁 𝗟𝗜𝗡𝗡𝗖 𝗣𝗮𝗿𝗶𝘀 𝟮𝟬𝟮𝟱 and discover a new way of learning the #WallabyPhenox products! #WallabyPhenox #SLICE #LINNC2025
🧠 Treat unique stroke cases with LINNC online faculty - only at #LINNCParis 𝗝𝘂𝗻𝗲 𝟮-𝟰, 2025! For the first time, SLICE 𝗮𝗻𝗱 𝗟𝗜𝗡𝗡𝗖 𝗮𝗿𝗲 𝘁𝗲𝗮𝗺𝗶𝗻𝗴 𝘂𝗽 to offer a 𝗵𝗮𝗻𝗱𝘀-𝗼𝗻 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 focused on treatment of ischemic and hemorrhagic stroke pathologies. Under the expert guidance of the 𝗟𝗜𝗡𝗡𝗖 𝗳𝗮𝗰𝘂𝗹𝘁𝘆 coming from all over the world, this interactive experience gives you a unique opportunity 𝘁𝗼 𝗵𝗮𝘃𝗲 𝗳𝗮𝗰𝗲-𝘁𝗼-𝗳𝗮𝗰𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻𝘀 𝗶𝗻 𝘀𝗺𝗮𝗹𝗹 𝗴𝗿𝗼𝘂𝗽𝘀 to: - explore treatment decisions and strategies - delve into anatomical understanding with medical imaging - experience sizing procedure and pharmacology - solve cases with tips and tricks for device implantation. Whether you are an 𝗲𝘅𝗽𝗲𝗿𝗶𝗺𝗲𝗻𝘁𝗲𝗱 𝗜𝗡𝗥 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗶𝗮𝗻 𝗼𝗿 𝗮 𝗳𝗲𝗹𝗹𝗼𝘄 𝘀𝘁𝗮𝗿𝘁𝗶𝗻𝗴 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗶𝗻𝗴 𝘁𝗵𝗿𝗼𝗺𝗯𝗲𝗰𝘁𝗼𝗺𝗶𝗲𝘀, this hands-on challenge promises high-level debates, strategic analysis, and significant knowledge enhancement. Join the 𝗦𝗟𝗜𝗖𝗘 𝗵𝗮𝗻𝗱𝘀-𝗼𝗻 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 𝗮𝘁 𝗟𝗜𝗡𝗡𝗖 𝗣𝗮𝗿𝗶𝘀 𝟮𝟬𝟮𝟱 and discover a new way of learning! 👉 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄 𝗮𝗻𝗱 𝘀𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝘀𝗽𝗼𝘁. https://lnkd.in/e5XRp3uh
-
We just had an amazing first day at the #APSCVIR. 👏🏻 Thank you to Prof Laurent Pierot for sharing insights on the COATING study and the future of aneurysm treatment. It was such an exciting topic!🌐 One down, two more days to go! Come and join us at our booth to connect and discover the latest technologies from WallabyPhenox. 🧠 See you tomorrow!👋🏻 #WallabyPhenox #Neurointervention
-